C-Reactive Protein Versus Hemogram-Derived Inflammatory Indices in Infants Evaluated for Hemodynamically Significant Patent Ductus Arteriosus
Journal of Cardiovascular Development and Disease · 16.11.2026 · 13 (11) · 602
DOI: 10.3390/jcdd13110602 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 16.11.2026. Verfasst von Adnan Azizoğlu und 7 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ductal patency in preterm infants is partly inflammation-driven, and hemogram-derived systemic inflammatory indices have been proposed as accessible markers of a hemodynamically significant patent ductus arteriosus (hsPDA). Whether these indices carry information beyond gestational age and routinely measured C-reactive protein (CRP), and whether their temporal trajectory differs in hsPDA, are unknown, particularly in real-world cohorts evaluated for hsPDA across a broad gestational-age range.
Methods
In this single-center retrospective cohort, 79 infants of 24–40 weeks’ gestation (including 10 born at term) undergoing echocardiographic evaluation of the ductus (December 2024–July 2026) had complete blood counts and CRP at two predefined windows (0–48 h and 48–120 h). Six indices (NLR, PLR, MLR, SII, SIRI, PIV) and their between-sampling change were compared by hsPDA status (diameter ≥ 1.5 mm, LA/Ao > 1.4, unrestrictive left-to-right flow), with Benjamini–Hochberg correction, ROC analysis, and gestational-age-adjusted logistic models including CRP.
Results
Thirty-six infants (45.6%) had hsPDA. No first-sample index differed between groups (all p > 0.7; AUC 0.48–0.51). At the second sampling, NLR (p = 0.009), SIRI (p = 0.007), and MLR (p = 0.031) were higher in hsPDA, as was the between-sampling change in MLR (ΔMLR, p = 0.006); however, no index remained significant after multiplicity correction (smallest q = 0.057), and none of these differences persisted in samples drawn before treatment. Second-sample CRP was the strongest discriminator (AUC 0.894, 95% CI 0.815–0.960). After adjustment for gestational age and surfactant therapy (Firth regression), CRP remained independently associated with hsPDA (OR 1.91 per doubling, 95% CI 1.47–2.68), whereas MLR did not (OR 1.07 per SD, 95% CI 0.60–2.44).
Conclusions
In infants of mixed gestational age evaluated for ductal patency, CRP measured around the time of diagnosis discriminated hsPDA better than all six hemogram-derived indices, which carried no information independent of CRP or respiratory illness severity. CRP rose concurrently with, rather than ahead of, hemodynamic significance, and its signal lay largely at the low end of the measurable range; neither CRP nor the indices should be regarded as predictors of hsPDA.
Zitieren
APA
Azizoğlu, A., Hocaoğlu, M., Alakaş, Y., Timurağaoğlu, L., Talay, M. N., Orhan, Ö., Unay, E. S., & Güzelbağ, A. N. (2026). C-Reactive Protein Versus Hemogram-Derived Inflammatory Indices in Infants Evaluated for Hemodynamically Significant Patent Ductus Arteriosus. Journal of Cardiovascular Development and Disease, 13(11), 602. https://doi.org/10.3390/jcdd13110602
Vancouver
Azizoğlu A, Hocaoğlu M, Alakaş Y, Timurağaoğlu L, Talay MN, Orhan Ö, et al. C-Reactive Protein Versus Hemogram-Derived Inflammatory Indices in Infants Evaluated for Hemodynamically Significant Patent Ductus Arteriosus. Journal of Cardiovascular Development and Disease. 2026;13(11):602. doi:10.3390/jcdd13110602
BibTeX
@article{Azizolu2026,
author = {Azizoğlu, Adnan and Hocaoğlu, Muhammet and Alakaş, Yusuf and Timurağaoğlu, Lokman and Talay, Mehmet Nur and Orhan, Özhan and Unay, Eylem Sezgen and Güzelbağ, Ali Nazım},
title = {C-Reactive Protein Versus Hemogram-Derived Inflammatory Indices in Infants Evaluated for Hemodynamically Significant Patent Ductus Arteriosus},
journal = {Journal of Cardiovascular Development and Disease},
year = {2026},
volume = {13},
number = {11},
pages = {602},
doi = {10.3390/jcdd13110602}
}
EUVIMED